Effect of COVID-19 pandemic on diagnosis and treatment of thyroid cancer in Brazil

Frontiers in Endocrinology - Tập 13
Vitor Bock Silveira1, Wallace Klein Schwengber1, Guilherme Moreira Hetzel1, André Borsatto Zanella1, Rafael Selbach Scheffel1, Ana Luiza Maia1, José Miguel Dora1
1Thyroid Unit, Endocrine Division, Hospital de Clínicas de Porto Alegre, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

Tóm tắt

IntroductionThe COVID-19 pandemic delayed the diagnosis, treatment, and follow-up visits of patients with thyroid cancer. However, the magnitude with which these restrictions affected the Brazilian health care is still unknown.MethodsRetrospective analysis of thyroid cancer-related procedures performed in the Brazilian public health system from 2019 to 2021. Data were retrieved from the Department of Informatics of the Unified Health System (DATASUS). The following procedures were evaluated: fine-needle aspiration biopsies (FNABs), oncologic thyroidectomies, and radioiodine (RAI) therapies for thyroid cancer. The year of 2019 served as baseline control.ResultsCompared with 2019, FNABs, oncologic thyroidectomies, and RAI therapies performed in 2020 decreased by 29%, 17% and 28%, respectively. In 2021, compared with 2019, FNABs increased by 2%, and oncologic thyroidectomies and RAI therapies decreased by 5% and 25%, respectively. Most pronounced reductions were observed in the first months of the pandemic. In April 2020, FNABs decreased by 67%, oncologic thyroidectomies by 45%, and RAI therapies by 75%. In 2021, RAI therapies were the only procedure with a statistically significant decrease.ConclusionThe restrictions to public health care during the COVID-19 pandemic resulted in a significant reduction in diagnostic and treatment procedures for thyroid cancer in Brazil. The effects of these transitory gaps in thyroid cancer care, due to COVID-19, are still unclear.

Từ khóa


Tài liệu tham khảo

de Souza, 2020, Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil, Nat Hum Behav, 4, 10.1038/s41562-020-0928-4

Liang, 2020, Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Lancet Oncol, 21, 10.1016/S1470-2045(20)30096-6

Bibbins-Domingo, 2017, Screening for thyroid cancer: US preventive services task force recommendation statement, JAMA, 317, 10.1001/jama.2017.4011

Martins, 2021, Management of thyroid disorders during the COVID-19 outbreak: a position statement from the thyroid department of the Brazilian society of endocrinology and metabolism (SBEM), Arch Endocrinol Metab, 65, 10.20945/2359-3997000000352

Li, 2020, Considerations for thyroid fine needle aspiration (FNA) biopsies during the COVID-19 pandemic, Clin Thyroidol, 32, 10.1089/ct.2020;32.156-158

Freudenberg, 2020, Global impact of COVID-19 on nuclear medicine departments: An international survey in April 2020, J Nucl Med, 61, 10.2967/jnumed.120.249821

Smulever, 2020, Thyroid cancer in the era of COVID-19, Endocrine, 70, 1, 10.1007/s12020-020-02439-6

Medas, 2021, Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study, Br J Surg, 108, 10.1093/bjs/znab012

Paim, 2011, The Brazilian health system: history, advances, and challenges, Lancet, 377, 10.1016/S0140-6736(11)60054-8

2020, Informações sobre domicílios, acesso e utilização dos serviços de saúde, Pesquisa nacional de saúde 2019

Cristo, 2016, Increasing diagnostic effectiveness of thyroid nodule evaluation by implementation of cell block preparation in routine US-FNA analysis, Arch Endocrinol Metab, 60, 10.1590/2359-3997000000180

Falta de verba faz ipen anunciar suspensão de produção de remédios para câncer2021

Schwengber, 2020, Patterns of radioiodine use for differentiated thyroid carcinoma in Brazil: insights and a call for action from a 20-year database, Arch Endocrinol Metab, 64, 10.20945/2359-3997000000302

Lortet-Tieulent, 2019, Thyroid cancer “epidemic” also occurs in low- and middle-income countries, Int J Cancer, 144, 10.1002/ijc.31884

Nickel, 2021, Delays to low-risk thyroid cancer treatment during COVID-19-Refocusing from what has been lost to what may be learned and gained, JAMA Otolaryngol Head Neck Surg, 147, 10.1001/jamaoto.2020.3878

Dora, 2021, Choosing wisely for thyroid conditions: Recommendations of the thyroid department of the Brazilian society of endocrinology and metabolism, Arch Endocrinol Metab, 65, 10.20945/2359-3997000000323

Grani, 2022, COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment, Endocrine Abstracts Biosci, 10.1530/endoabs.81.P458

Yang, 2022, Psychological health status among thyroid cancer patients during the COVID-19 epidemic in China, Support Care Cancer, 30, 10.1007/s00520-021-06624-9

Falcone, 2020, Cancer care during COVID-19 era: The quality of life of patients with thyroid malignancies, Front Oncol, 10, 10.3389/fonc.2020.01128

Thông tin
Thông tin xuất bản

Frontiers in Endocrinology

Tập 13

Thông tin tác giả